Gigi Hirsch, MD, Executive Director, MIT-CBI

Gigi Hirsch, MD, Executive Director, MIT-CBI

Collaborative Innovation > Transformation Impact

animated image
  • CBI's collaborative model invites experts from industry, government and academia together to create and sustain a unique Safe Haven environment, where they can share ideas, conduct research and educate for action.
  • We challenge existing assumptions about the pre-competitive space, working to understand where the benefits of information sharing in the evolving industry outweigh the competitive risks.
  • Our research success metrics focus on real world implementation across the entire innovation chain, resulting in transformation of the system.

Welcome

The mission of the Center for Biomedical Innovation (CBI) is to improve patient care worldwide by sustaining a safe haven where experts in academia, government and industry work together to develop and implement solutions to real world healthcare challenges.

The CBI is a collaborative effort across the Schools of Science, Engineering, and Management of the Massachusetts Institute of Technology (MIT), the Harvard-MIT Division of Health Sciences and Technology (HST), government agencies involved in healthcare, and members of the pharmaceutical and biotechnology industries.

We welcome thought leaders across the biomedical spectrum - from medical researchers to federal regulators and payers, to experts in finance and marketing - to participate in pre-competitive research and catalyze industry-wide adoption of the resulting solutions.

Events and News

Events

  • April 2, 2008: CBI launched the Transforming Biomedical Innovation Roundtable Discussion series. Distinguished panelists from the FDA, the NIH, the CDC, the Engleberg Center for Healthcare Reform and MIT led an exciting discussion on "The Role of Government in Innovation". MIT news article is available here.
  • April 2, 2008: Dr. Julie Gerberding, Director of the CDC, launches CBI's new Transforming Biomedical Innovation lecture series with "Health System Transformation: Getting our Money's Worth of 'Healthness'" introduced by MIT President Susan Hockfield. See details here.
  • March 13, 2008: CBI held a workshop entitled Safety Surveillance: Translating Knowledge from Other Industries. Agenda and workshop summary information available here.

News

  • January 15, 2008: Dr. Gigi Hirsch was named Executive Director of CBI and Prof. Anthony Sinskey was named Faculty Director.

Research

Research Areas

The CBI is focused on optimizing biomedical innovation through collaborative effort in several research areas, including:
  • Safety Assessment
  • Manufacturing and Distribution Systems
  • Economic, Financial & Regulatory Risk Management
  • R&D Redesign

  • Research Programs

    Safety Surveillance
  • Biomanufacturing

  • Click here to see a complete list of our Research Programs and Research Projects.